Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia

Experimental Eye Research

Volumn 77, Issue 2, 2003, Pages 137-145

  Ju, Won Kyu ^a   Kim, Keun Young ^a   Neufeld, Arthur H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood retinal barrier; Cyclooxygenase 2; Microglia; M ller cells; Retinal ganglion cells

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD RETINA BARRIER; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG SELECTIVITY; ENZYME ACTIVITY; EYE MOVEMENT; IMMUNOREACTIVITY; MALE; MUELLER CELL; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RAT; RETINA AMACRINE CELL; RETINA ISCHEMIA; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

EID: 0038166242     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(03)00128-3     Document Type: Article

References (57)

1. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
2. Banati R.B., Graeber M.B. Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev. Neurosci. 16:1994;114-127.
3. Bazan N.G. The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog. Brain Res. 118:1998;281-291.
4. Bazan N.G. COX-2 as a multifunctional neuronal modulator. Nat. Med. 7:2001;414-415.
5. Bazan N.G., Palacios-Pelaez R., Lukiw W.J. Hypoxia signaling to genes: significance in Alzheimer's disease. Mol. Neurobiol. 26:2002;283-298.
6. Breder C.D., Dewitt D., Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355:1995;296-315.
7. Buchi E.R., Suivaizdis I., Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica. 203:1991;138-147.
8. Chang-Ling T., Neill A.L., Hunt N.H. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am. J. Pathol. 140:1992;1121-1130.
9. Chao C.C., Hu S., Peterson P.K. Modulation of human microglial cell superoxide production by cytokines. J. Leukoc. Biol. 58:1995;65-70.
10. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
11. Collaco-Moraes Y., Aspey B., Harrison M., de Belleroche J. Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1996;1366-1372.
12. Colton C., Wilt S., Gilbert D., Chernyshev O., Snell J., Dubois-Dalcq M. Species differences in the generation of reactive oxygen species by microglia. Mol. Chem. Neuropathol. 28:1996;15-20.
13. Degi R., Bari F., Beasley T.C., Thrikawala N., Thore C., Louis T.M., Busija D.W. Regional distribution of prostaglandin H synthase-2 and neuronal nitric oxide synthase in piglet brain. Pediatr. Res. 43:1998;683-689.
14. Degi R., Thore C., Bari F., Thrikawala N., Nogradi A., Robins G., Domoki F., Beasley T.C., Busija D.W. Ischemia increases prostaglandin H synthase-2 levels in retina and visual cortex in piglets. Graefes. Arch. Clin. Exp. Ophthalmol. 239:2001;59-65.
15. Dong K., Ahmed A.K., Qu T., Sugioka K., Yamada K., Yamadori T. Retrograde fluorescent double-labeling study of bilaterally projecting retinal ganglion cells in albino rats at different stages of development. Brain Res. Dev. Brain Res. 95:1996;55-62.
16. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
17. Govoni S., Masoero E., Favalli L., Rozza A., Scelsi R., Viappiani S., Buccellati C., Sala A., Folco G. The cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci. Lett. 303:2001;91-94.
18. Gründer T., Kohler K., Guenther E. Alterations in NMDA receptor expression during retinal degeneration in the RCS rat. Vis. Neurosci. 18:2001;781-787.
19. Gründer T., Kohler K., Kaletta A., Guenther E. The distribution and developmental regulation of NMDA receptor subunit proteins in the outer and inner retina of the rat. J. Neurobiol. 44:2000;333-342.
20. Herschman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta. 9:1996;125-140.
21. Hewett S.J., Uliasz T.F., Vidwans A.S., Hewett J.A. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J. Pharmacol. Exp. Ther. 293:2000;417-425.
22. Hirst W.D., Young K.A., Newton R., Allport V.C., Marriott D.R., Wilkin G.P. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell Neurosci. 13:1999;57-68.
23. Ho L., Pieroni C., Winger D., Purohit D.P., Aisen P.S., Pasinetti G.M. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res. 57:1999;295-303.
24. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., Ross M.E. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Nat. Acad. Sci. USA. 98:2001;1294-1299.
25. Iadecola C., Ross M.E. Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection. Ann. NY Acad. Sci. 835:1997;203-217.
26. Joo C.K., Choi J.S., Ko H.W., Park K.Y., Sohn S., Chun M.H., Oh Y.J., Gwag B.J. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest. Ophthalmol. Vis. Sci. 40:1999;713-720.
27. Ju W.K., Gwon J.S., Kim K.Y., Oh S.J., Kim S.Y., Chun M.H. Up-regulated eNOS protects blood-retinal barrier in the L-arginine treated ischemic rat retina. Neuroreport. 12:2001;2405-2409.
28. Ju W.K., Kim K.Y., Hofmann H.D., Kim I.B., Lee M.Y., Oh S.J., Chun M.H. Selective neuronal survival and upregulation of PCNA in the rat inner retina following transient ischemia. J. Neuropathol. Exp. Neurol. 59:2000;241-250.
29. Ju W.K., Neufeld A.H. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. J. Comp. Neurol. 452:2002;392-399.
30. Kawai S.I., Vora S., Das S., Gachie E., Becker B., Neufeld A.H. Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: effects of age, caloric restriction, diabetes, pigmentation, and glaucoma. FASEB J. 15:2001;1285-1287.
31. Klegeris A., McGeer P.L. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol. Aging. 23:2002;787-794.
32. Koistinaho J., Koponen S., Chan P.H. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. Stroke. 30:1999;1900-1905.
33. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
34. Kunz T., Oliw E.H. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci. 13:2001;569-575.
35. Lapchak P.A., Araujo D.M., Song D., Zivin J.A. Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia. Stroke. 32:2001;1220-1225.
36. Li L., Prabhakaran K., Shou Y., Borowitz J.L., Isom G.E. Oxidative stress and cyclooxygenase-2 induction mediate cyanide-induced apoptosis of cortical cells. Toxicol. Appl. Pharmacol. 185:2002;55-63.
37. Lombardi G., Moroni F., Moroni F. Glutamate receptor antagonists protect against ischemia-induced retinal damage. Eur. J. Pharmacol. 271:1994;489-495.
38. Maslinska D., Wozniak R., Kaliszek A., Modelska I. Expression of cyclooxygenase-2 in astrocytes of human brain after global ischemia. Folia Neuropathol. 37:1999;75-79.
39. Miettinen S., Fusco F.R., Yrjanheikki J., Keinanen R., Hirvonen T., Roivainen R., Narhi M., Hokfelt T., Koistinaho J. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc. Nat. Acad. Sci. USA. 94:1997;6500-6505.
40. Nagayama M., Niwa K., Nagayama T., Ross M.E., Iadecola C. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J. Cereb. Blood Flow. Metab. 19:1999;1213-1219.
41. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Nat. Acad. Sci. USA. 95:1998;10954-10959.
42. Neufeld A.H., Kawai S., Das S., Vora S., Gachie E., Connor J.R., Manning P.T. Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp. Eye Res. 75:2002;521-528.
43. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17:1997;2746-2755.
44. Osborne N.N., Wood J.P., Cupido A., Melena J., Chidlow G. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Invest. Ophthalmol. Vis. Sci. 43:2002;1456-1464.
45. Roque R.S., Caldwell R.B. Isolation and culture of retinal microglia. Curr. Eye Res. 12:1993;285-290.
46. Sairanen T., Ristimaki A., Karjalainen-Lindsberg M.L., Paetau A., Kaste M., Lindsberg P.J. Cyclooxygenase-2 is induced globally in infarcted human brain. Ann. Neurol. 43:1998;738-747.
47. Seibert K., Masferrer J., Zhang Y., Gregory S., Olson G., Hauser S., Leahy K., Perkins W., Isakson P. Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl. 46:1995;41-50.
48. Selles-Navarro I., Villegas-Perez M.P., Salvador-Silva M., Ruiz-Gomez J.M., Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 37:1996;2002-2014.
49. Strauss K.I., Barbe M.F., Marshall R.M., Raghupathi R., Mehta S., Narayan R.K. Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. J. Neurotrauma. 17:2000;695-711.
50. Strauss K.I., Marini A.M. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J. Neurotrauma. 19:2002;627-638.
51. Takadera T., Yumoto H., Tozuka Y., Ohyashiki T. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci. Lett. 317:2002;61-64.
52. Tocco G., Freire-Moar J., Schreiber S.S., Sakhi S.H., Aisen P.S., Pasinetti G.M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp. Neurol. 144:1997;339-349.
53. Tomimoto H., Akiguchi I., Wakita H., Lin J.X., Budka H. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans. Acta Neuropathol. (Berl). 99:2000;26-30.
54. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120.
55. Wakita H., Tomimoto H., Akiguchi I., Lin J.X., Miyamoto K., Oka N. A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia. Neuroreport. 10:1999;1461-1465.
56. Wilson C.A., Berkowitz B.A., Funatsu H., Metrikin D.C., Harrison D.W., Lam M.K., Sonkin P.L. Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion. Exp. Eye Res. 61:1995;547-557.
57. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.